Gemcitabine (G) plus cisplatin (C) is a highly active regimen in first-line treatment of metastatic breast cancer (MBC): Results of a multicenter phase II trial

被引：0
作者：
Fuentes, H
Calderillo, G
Alexander, F
Ramirez, M
Avila, E
Perez, L
Aguirre, C
机构：
[1] Inst Nacl Cancerol, SSA, Mexico City, DF, Mexico
[2] Hosp Gen Occidente Seguro Social, SSA, Oncol Serv, Guadalajara, Jalisco, Mexico
[3] IMSS, Unidad Morelos 1, Cuernavaca, Morelos, Mexico
[4] Ctr Med Potosi, Oncol & Radiotherapy Serv, San Luis Potosi, Mexico
[5] Clin ISSSTE, Oncol Serv, Ensenada, Baja California, Mexico
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷
关键词：
D O I：
10.1016/S0959-8049(02)80216-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [21] A Phase II Trial of Gemcitabine/Carboplatin with or Without Trastuzumab in the First-Line Treatment of Patients with Metastatic Breast Cancer
    Yardley, Denise A.
    Burris, Howard. A., III
    Simons, Lisa
    Spigel, David R.
    Greco, E. Anthony
    Barton, John H.
    Shipley, Dianna
    Drosick, David
    Hainsworth, John D.
    CLINICAL BREAST CANCER, 2008, 8 (05) : 425 - 431
  • [22] Gemcitabine plus cisplatin combination as second-line treatment in patients with metastatic breast cancer (MBC).
    Ajarim, D
    Ezzat, A
    Bazarbashi, S
    Rahal, M
    El Foudeh, M
    Pai, C
    Raja, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 70S - 70S
  • [23] Gemcitabine plus vinorelbine as first-line treatment of metastatic breast cancer.
    Gokmen, E
    Sezgin, C
    Karabulut, B
    Vazquez, A
    Sanal, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 85S - 85S
  • [24] A phase II trial of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer
    Meshref, M. M.
    Samir, S.
    Saad, E.
    Gouda, Y.
    Elmesidy, S.
    Koheil, H.
    Elzawahri, H.
    Kandil, A.
    Abdelhamid, T.
    Zaki, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] First-line chemotherapy of advanced or metastatic breast cancer (MBC) with docetaxel and doxorubicin in Indonesia: results from A phase II trial
    Abdulmuthalib
    Darwis, Idral
    Prayogo, Nugroho
    Sutjipto
    MEDICAL JOURNAL OF INDONESIA, 2005, 14 (01) : 20 - 25
  • [26] Phase Ib/II trial of gemcitabine, cisplatin, plus lenalidomide as first-line therapy for patients with metastatic urothelial carcinoma
    Tsao, Che-Kai
    Agarwal, Neeraj
    Apolo, Andrea Borghese
    Lee, Karen M.
    Godbold, James H.
    Oh, William K.
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [27] FIRST LINE BE-WEEKLY REGIMEN WITH DOCETAXEL AND GEMCITABINE IN HER-2 NEGATIVE AND ANTRACYCLINE-PRETREATED METASTATIC BREAST CANCER (MBC) PATIENTS: PRELIMINARY RESULTS OF A MULTICENTER PHASE II TRIAL
    Murialdo, R.
    Bertolotti, F.
    Tixi, L.
    Boy, D.
    Martini, M. C.
    Pastorino, G.
    Sogno, G.
    Vaira, F.
    Bergaglio, M.
    Mencoboni, M.
    Simoni, C.
    Parodi, M.
    Canobbio, L.
    Folco, U.
    Ballestrero, A.
    Brema, F.
    ANNALS OF ONCOLOGY, 2009, 20
  • [28] Gemcitabine (G) plus cisplatin (C) plus radiotherapy in first-line treatment of locally advanced and metastatic undifferentiated carcinoma of the nasopharyngeal type (UCNT): Preliminary results of a phase II study.
    Adane, S
    Sadouki, M
    Mekki, F
    Bouzid, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 517S - 517S
  • [29] Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer
    Chua, Daniel T. T.
    Yiu, Harry Ho-Yin
    Seetalarom, Kasan
    Ng, Alice Wan-Ying
    Kurnianda, Johan
    Shotelersuk, Kanjana
    Krishnan, Gopala
    Hong, Ruey-Long
    Yang, Muh-Hwa
    Wang, Cheng-Hsu
    Sze, Wing-Kin
    Ng, Wai-Tong
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (09): : 1225 - 1230
  • [30] Phase I/II Gemcitabine (G) with Pegylated Liposomal Doxorubicin (PLD) as first-line therapy in metastatic breast cancer (MBC) in Asian women
    Wong, Zee Wan
    Shah, Valencia A.
    Wong, Nan Soon
    Ang, Peter Cher Siang
    Silverman, Carrie
    Tan, Say Beng
    Cheung, Yin Bun
    Chowbay, Balram
    See, Hui Ti
    Khoo, Kei Siong
    ANNALS OF ONCOLOGY, 2004, 15 : 43 - 43
12345